HEALTH ITALIA SPA (HI.MI) Fundamental Analysis & Valuation

BIT:HI • IT0005585861

Current stock price

300 EUR
+1 (+0.33%)
Last:

This HI.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HI.MI Profitability Analysis

1.1 Basic Checks

  • In the past year HI was profitable.
  • HI had a positive operating cash flow in the past year.
  • Each year in the past 5 years HI has been profitable.
  • In the past 5 years HI always reported a positive cash flow from operatings.
HI.MI Yearly Net Income VS EBIT VS OCF VS FCFHI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • HI has a better Return On Assets (6.33%) than 90.91% of its industry peers.
  • HI has a Return On Equity of 12.31%. This is in the better half of the industry: HI outperforms 75.76% of its industry peers.
  • HI has a better Return On Invested Capital (7.54%) than 78.79% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HI is in line with the industry average of 6.20%.
  • The 3 year average ROIC (7.13%) for HI is below the current ROIC(7.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROIC 7.54%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
HI.MI Yearly ROA, ROE, ROICHI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • The Profit Margin of HI (8.64%) is better than 93.94% of its industry peers.
  • HI's Profit Margin has improved in the last couple of years.
  • The Operating Margin of HI (13.27%) is better than 90.91% of its industry peers.
  • In the last couple of years the Operating Margin of HI has grown nicely.
  • HI has a better Gross Margin (29.23%) than 63.64% of its industry peers.
  • HI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
HI.MI Yearly Profit, Operating, Gross MarginsHI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. HI.MI Health Analysis

2.1 Basic Checks

  • HI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • HI has more shares outstanding than it did 1 year ago.
  • HI has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HI has been reduced compared to a year ago.
HI.MI Yearly Shares OutstandingHI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HI.MI Yearly Total Debt VS Total AssetsHI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.16 indicates that HI is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.16, HI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that HI is not too dependend on debt financing.
  • HI's Debt to Equity ratio of 0.30 is amongst the best of the industry. HI outperforms 93.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.16
ROIC/WACC1.02
WACC7.37%
HI.MI Yearly LT Debt VS Equity VS FCFHI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • HI has a Current Ratio of 2.47. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.47, HI belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
  • HI has a Quick Ratio of 2.47. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.47, HI belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
HI.MI Yearly Current Assets VS Current LiabilitesHI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HI.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.67% over the past year.
  • The Earnings Per Share has been growing by 181.50% on average over the past years. This is a very strong growth
  • HI shows a decrease in Revenue. In the last year, the revenue decreased by -4.22%.
  • The Revenue has been growing slightly by 2.37% on average over the past years.
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. HI.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.51, the valuation of HI can be described as rather expensive.
  • HI's Price/Earnings ratio is a bit more expensive when compared to the industry. HI is more expensive than 63.64% of the companies in the same industry.
  • HI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.51
Fwd PE N/A
HI.MI Price Earnings VS Forward Price EarningsHI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • HI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.89
HI.MI Per share dataHI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The excellent profitability rating of HI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HI.MI Dividend Analysis

5.1 Amount

  • HI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HI.MI Fundamentals: All Metrics, Ratios and Statistics

HEALTH ITALIA SPA

BIT:HI (3/12/2026, 7:00:00 PM)

300

+1 (+0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.00M
Revenue(TTM)35.60M
Net Income(TTM)3.08M
Analysts84.44
Price Target372.3 (24.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.51
Fwd PE N/A
P/S 1.6
P/FCF N/A
P/OCF 45.07
P/B 2.28
P/tB 2.68
EV/EBITDA 9.89
EPS(TTM)16.21
EY5.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.46
FCFYN/A
OCF(TTM)6.66
OCFY2.22%
SpS187.37
BVpS131.59
TBVpS112.11
PEG (NY)N/A
PEG (5Y)0.1
Graham Number219.08
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROCE 13.76%
ROIC 7.54%
ROICexc 8.33%
ROICexgc 9.39%
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
FCFM N/A
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexgc growth 3Y-3.65%
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 1.28
Cap/Depr 242.82%
Cap/Sales 7.54%
Interest Coverage 250
Cash Conversion 21.7%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 3.16
F-Score4
WACC7.37%
ROIC/WACC1.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.56%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.27%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y-61.44%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%

HEALTH ITALIA SPA / HI.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HI.MI.


What is the valuation status of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTH ITALIA SPA (HI.MI). This can be considered as Overvalued.


Can you provide the profitability details for HEALTH ITALIA SPA?

HEALTH ITALIA SPA (HI.MI) has a profitability rating of 8 / 10.


How financially healthy is HEALTH ITALIA SPA?

The financial health rating of HEALTH ITALIA SPA (HI.MI) is 7 / 10.


How sustainable is the dividend of HEALTH ITALIA SPA (HI.MI) stock?

The dividend rating of HEALTH ITALIA SPA (HI.MI) is 0 / 10 and the dividend payout ratio is 0%.